How many and which vaccines have been ordered for Estonia
For buying the vaccines, Estonia is participating in the European Union joint procurement which has been joined by all member states. Altogether, the vaccines of eight vaccine manufacturers are in the European Commission joint procurement portfolio of vaccines. As of right now, Estonia has joined the pre-purchasing agreements with five manufacturers but the government has also given its approval for joining the contracts with other manufacturers.
Along with the Valneva contract that has been added to the joint European Union vaccine portfolio, Estonia has the possibility to acquire 5,229,362 doses altogether, for 2,764,681 people.
Vaccine | Vaccine type | Marketing authorization or the current state of the application process | How many people it has been ordered for |
Pfizer/BioNTech Comirnaty | mRNA | Conditional marketing authorisation from December 21 | 857 214 |
Moderna | mRNA | Conditional marketing authorisation from January 6 | 122 134 |
Vaxzevria (AstraZeneca) | Adenovirus | Conditional marketing authorisation from January 29 | 665 000 |
Janssen Pharmaceutica (Johnson & Johnson) | Adenovirus | Conditional marketing authorisation from March 11 | 300 000 |
Curevac | mRNA | No marketing authorisation yet | 329 692 |
Sanofi | Protein-based | No marketing authorisation yet | 300 000 |
Novavax | Protein-based | No marketing authorisation yet | 146 542 |
Valneva | Inactivated | No marketing authorisation yet | 44 000 |
COVID-19 vaccines information
- Overview of the vaccines that are currently being reviewed at the European Medicines Agency can be found here.
- Read here how COVID-19 vaccines are developed evaluated, approved and monitored.
Frequently asked questions about COVID-19 vaccines
- Why are vaccines to prevent COVID-19 needed?
- Is there a vaccine to protect against COVID-19?
- What process and methods are used to develop and approve COVID-19 vaccines?
- Why did development only start after the pandemic was declared?
- When will the vaccines be approved?
- What type and amount of data is needed for approving a safe and effective vaccine?
- How long will immunity from a vaccine last?
- Can vaccines protect people against the virus when it has mutated?
- How are vaccines being rolled out in the EU?
- How is rapid, large-scale manufacturing kept safe in the EU?
- How are vaccines kept safe during distribution?